LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Continente #
NA - Nord America 12.991
EU - Europa 10.284
AS - Asia 5.775
SA - Sud America 1.005
Continente sconosciuto - Info sul continente non disponibili 473
AF - Africa 303
OC - Oceania 20
AN - Antartide 1
Totale 30.852
Nazione #
US - Stati Uniti d'America 12.779
IT - Italia 2.001
CN - Cina 1.984
RU - Federazione Russa 1.915
GB - Regno Unito 1.869
SG - Singapore 1.787
IE - Irlanda 1.177
BR - Brasile 839
DE - Germania 768
SE - Svezia 717
UA - Ucraina 548
VN - Vietnam 542
FR - Francia 518
HK - Hong Kong 455
FI - Finlandia 388
KR - Corea 312
IN - India 198
CA - Canada 117
ZA - Sudafrica 114
BD - Bangladesh 110
NL - Olanda 76
TR - Turchia 69
ES - Italia 67
AR - Argentina 57
IQ - Iraq 54
CI - Costa d'Avorio 49
MX - Messico 49
PL - Polonia 43
NG - Nigeria 41
JP - Giappone 39
BE - Belgio 38
EC - Ecuador 30
KE - Kenya 30
CZ - Repubblica Ceca 29
AT - Austria 27
PK - Pakistan 25
CO - Colombia 22
TH - Thailandia 22
ID - Indonesia 21
VE - Venezuela 21
GR - Grecia 18
AU - Australia 16
EG - Egitto 14
PH - Filippine 14
TN - Tunisia 14
UZ - Uzbekistan 14
IL - Israele 13
MA - Marocco 13
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
JM - Giamaica 10
JO - Giordania 10
KZ - Kazakistan 10
RO - Romania 10
AZ - Azerbaigian 9
CL - Cile 9
CH - Svizzera 8
DZ - Algeria 8
IR - Iran 8
NP - Nepal 8
PY - Paraguay 8
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
MY - Malesia 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
PE - Perù 6
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
HN - Honduras 5
HR - Croazia 5
OM - Oman 5
RS - Serbia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
NZ - Nuova Zelanda 4
PA - Panama 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
GY - Guiana 3
LB - Libano 3
SN - Senegal 3
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
Totale 30.350
Città #
Southend 1.606
Dallas 1.540
Fairfield 1.169
Ashburn 1.144
Dublin 1.143
Singapore 987
Chandler 599
Santa Clara 552
Woodbridge 544
Moscow 537
Milan 536
San Jose 513
Houston 470
Beijing 466
Hefei 436
Hong Kong 436
Seattle 434
Jacksonville 428
Wilmington 424
Cambridge 395
Siena 365
Menlo Park 308
Seoul 305
Ann Arbor 291
Council Bluffs 253
Helsinki 237
Princeton 209
The Dalles 208
Los Angeles 183
New York 179
Rome 156
Nanjing 155
Lauterbourg 147
Ho Chi Minh City 144
Columbus 128
Dong Ket 125
Munich 116
Florence 115
Hanoi 111
Johannesburg 101
Boardman 99
Dearborn 94
Buffalo 92
San Diego 81
Vimercate 78
São Paulo 70
San Mateo 65
Nanchang 60
Bengaluru 57
Orem 55
Shanghai 51
Abidjan 49
Brooklyn 48
Chicago 47
Turku 47
Shenyang 44
London 42
Málaga 40
Toronto 40
Frankfurt am Main 39
Abuja 38
Brussels 36
Redondo Beach 36
San Francisco 36
Turin 36
Tokyo 34
Changsha 33
Lappeenranta 33
Warsaw 33
Amsterdam 31
Denver 29
Phoenix 29
Poggiomarino 29
Atlanta 28
Figino 28
Hebei 27
Montreal 27
Nuremberg 27
Boston 26
Guangzhou 26
Izmir 26
Lancaster 26
Mumbai 26
Tianjin 26
Düsseldorf 24
Jinan 24
Rio de Janeiro 24
Kunming 23
Belo Horizonte 21
Chennai 21
Jiaxing 21
Norwalk 21
Washington 20
Baghdad 19
Da Nang 19
Ankara 18
Fremont 18
Manchester 18
Poplar 18
Pune 18
Totale 20.446
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 426
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 426
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 404
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 399
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 394
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 374
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 373
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 370
Antirheumatic agents in covid-19: is IL-6 the right target? 368
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 344
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 325
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 321
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 319
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 316
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 306
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 306
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 303
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 301
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 299
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 289
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 289
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 285
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 284
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 282
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 277
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 277
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 275
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 263
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 262
Torsades de Pointes in patients with polymyalgia rheumatica 255
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 251
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 248
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 247
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 246
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 245
The role of P2X7 receptors in tissue fibrosis: a brief review 244
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 243
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 243
Editorial: Insights in General Cardiovascular Medicine: 2021 242
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 240
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 240
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 240
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 239
Human rheumatoid synoviocytes express functional P2X7 receptors 237
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 235
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 235
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 232
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 232
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 231
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 230
Statins and the joint: multiple targets for a global protection? 230
Connective tissue diseases and cardiac rhythm disorders: an overview 227
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 225
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 222
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 221
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 217
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 216
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 212
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 206
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 206
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 205
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 203
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 202
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 202
Pathogenesis of the novel autoimmune-associated long-QT syndrome 200
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 200
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 199
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 199
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 196
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 196
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 195
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 194
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 192
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 192
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 187
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 183
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 181
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 180
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 180
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 179
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 178
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 177
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 176
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 175
Photopheresis immunomodulation after heart transplantation. 174
Homocysteine and Raynaud’s phenomenon: a review 174
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 172
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans. 172
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 171
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 168
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 163
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 160
Editorial: Insights in general cardiovascular medicine: 2022 160
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 160
Homocysteine and P wave dispersion in patients with heart transplantation 159
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 156
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 156
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 155
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 154
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 151
Totale 23.870
Categoria #
all - tutte 96.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.759 0 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/20254.348 89 201 365 256 491 276 197 273 347 214 442 1.197
2025/202610.899 860 1.579 1.046 1.218 1.821 464 1.210 300 373 587 433 1.008
2026/2027824 523 301 0 0 0 0 0 0 0 0 0 0
Totale 30.852